RxDoctor Payments Data

Aimee Brooken

Pediatrics · Lansing, MINPI 1760746788

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 82 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) at 24.4% of the total. Among pediatrics clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,508in general payments, 2019–2025

Across 82 payments — averaging $18.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$368
  • Novo Nordisk$335
  • Pfizer$105
  • Merck$100
  • Otsuka America Pharmaceutical, Inc.$64
  • Lilly USA, LLC$64
  • plus $473 from 13 others

What the payments were for

  • Food & beverage$1,508100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,508 in reported general payments places this provider in the 90th percentile of 1,473 pediatrics providers in Michigan.

See all pediatrics providers in Michigan →

Other pediatrics in Lansing

See the full list for Michigan →

Where these figures come from

Is this you, or does something look wrong? →